Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jing Liu
Peking University Sixth Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Peking University Sixth Hospital
Beijing, China
Recruiting - the Second Xiangya Hospital of Central South University
Changsha, China
Not, yet, recruiting - West China Hospital of Sichuan University
Chengdu, China
Not, yet, recruiting - Nanjing Brain Hospital, the Affiliated Brain Hospital of Nanjing Medical University
Nanjing, China
Not, yet, recruiting - Tianjin Mental Health Center
Tianjin, China
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Jan 2025
- Primary completion
- 6 Feb 2026
- Completion
- 8 May 2026
- Last update posted
- 14 May 2025
- Registered enrollment
- 150
- Registry id
- NCT06757504
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.